PharmaCyte Biotech Inc (PMCB): PharmaCyte Biotech Provides Details on Q...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	17
Posts	1428
Boards Moderated	0
Alias Born	04/10/2006

pennyvestor

Re: None

Friday, 12/20/2019 12:41:53 AM

Friday, December 20, 2019 12:41:53 AM

PharmaCyte Biotech Provides Details on Quarterly Shareholder Update

December 19, 2019

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its quarterly shareholder update that is scheduled for December 20, 2019, at 4 P.M. EST must be rescheduled. The company’s resources are fully engaged in completing its 10-Q for the period ending October 31, 2019 and are being dedicated to submitting its Investigational New Drug application (IND) as quickly and correctly as possible.

PharmaCyte will provide further details on the rescheduling of the shareholder update when a new date is set by the company.

To learn more about PharmaCyte’s pancreatic cancer treatment and how it works inside the body to treat locally advanced inoperable pancreatic cancer, we encourage you to watch the company’s documentary video complete with medical animations at: https://www.PharmaCyte.com/Cancer

https://ir.pharmacyte.com/press-releases/detail/221